ArticleBioengineering (Basel, Switzerland)2026
Comparing Regenerative and Rehabilitative Strategies for Female Stress Urinary Incontinence: Platelet-Rich Plasma vs. Pelvic Floor Muscle Training-A Prospective Study Evaluating Quality of Life.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStress urinary incontinence (SUI) is one of the most common pelvic floor disorders in women, often impairing quality of life (QoL). Pelvic floor muscle training (PFMT) is the standard conservative therapy, while autologous platelet-rich plasma (PRP) is a newer minimally invasive regenerative option.
objectiveTo compare the effectiveness of three periurethral PRP injections versus PFMT in women with SUI.
methodsThis prospective cohort study included 169 women diagnosed with SUI, divided into a PRP group (n = 131), receiving three periurethral PRP injections at 4-6-month intervals, and a PFMT group (n = 38), completing a 12-week PFMT program. Outcomes were measured using the Stamey incontinence scale, visual analogue scale (VAS), and the King's Health Questionnaire (KHQ).
resultsAt baseline, PRP patients had more severe symptoms and worse QoL scores. After one injection, PRP achieved improvements in Stamey and VAS scores comparable to PFMT (lower scores), though KHQ remained superior in PFMT (significantly higher baseline scores in the PRP group than the PFMT group). The PRP group showed consistently larger within-group improvements across all scales (
conclusionsRepeated PRP treatment provides greater, controlled, and more consistent benefits than PFMT for SUI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.